BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33108455)

  • 1. Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
    Calvo X; Garcia-Gisbert N; Parraga I; Gibert J; Florensa L; Andrade-Campos M; Merchan B; Garcia-Avila S; Montesdeoca S; Fernández-Rodríguez C; Salido M; Puiggros A; Espinet B; Colomo L; Roman-Bravo D; Bellosillo B; Ferrer A; Arenillas L
    Blood Adv; 2020 Oct; 4(20):5285-5296. PubMed ID: 33108455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.
    Calvo X; Roman-Bravo D; Garcia-Gisbert N; Rodriguez-Sevilla JJ; Garcia-Avila S; Florensa L; Gibert J; Fernández-Rodríguez C; Salido M; Puiggros A; Espinet B; Colomo L; Bellosillo B; Ferrer A; Arenillas L
    Blood Adv; 2022 Jul; 6(13):3921-3931. PubMed ID: 35709473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
    Geyer JT; Tam W; Liu YC; Chen Z; Wang SA; Bueso-Ramos C; Oak J; Arber DA; Hsi E; Rogers HJ; Levinson K; Bagg A; Hassane DC; Hasserjian RP; Orazi A
    Mod Pathol; 2017 Sep; 30(9):1213-1222. PubMed ID: 28548124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
    Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
    Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How I investigate chronic myelomonocytic leukemia.
    Sangiorgio VFI; Arber DA; Orazi A
    Int J Lab Hematol; 2020 Apr; 42(2):101-108. PubMed ID: 31841277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
    Singh ZN; Post GR; Kiwan E; Maddox AM
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
    Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
    Castaño-Díez S; Pomares H; Esteban D; Guijarro F; Jiménez-Vicente C; Zugasti I; Álamo JR; Mayayo VT; López-Guerra M; de la Fuente C; Charry P; Cortés-Bullich A; Bataller Á; Maluquer C; Colomer D; Rozman M; Arnan M; Xicoy B; Esteve J; Díaz-Beyá M
    Br J Haematol; 2024 Mar; 204(3):892-897. PubMed ID: 38013238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ; Pan LJ; Qin TJ; Xu ZF; Li B; Wang HJ; Sun Q; Jia YJ; Li CW; Cai WY; Gao QY; Jiao M; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):373-379. PubMed ID: 37550186
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
    Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
    Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis.
    Hwang SM; Ahn H; Jeon S; Park J; Chang Y; Kim H
    J Clin Lab Anal; 2021 Jan; 35(1):e23576. PubMed ID: 32931067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia.
    Moon Y; Kim MH; Kim HR; Ahn JY; Huh J; Huh JY; Han JH; Park JS; Cho SR
    Ann Lab Med; 2018 Sep; 38(5):481-483. PubMed ID: 29797820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.
    Valent P
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101137. PubMed ID: 32460976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia.
    Cervera N; Itzykson R; Coppin E; Prebet T; Murati A; Legall S; Vey N; Solary E; Birnbaum D; Gelsi-Boyer V
    Am J Hematol; 2014 Jun; 89(6):604-9. PubMed ID: 24595958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.
    Padron E; Steensma DP
    Curr Opin Hematol; 2015 Mar; 22(2):163-70. PubMed ID: 25575034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y; Harada H
    Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating flow cytometry and next-generation sequencing in the diagnosis of CMML. Are we ready for prime?
    Solary E; Wagner-Ballon O; Selimoglu-Buet D
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101134. PubMed ID: 32460985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis.
    Cargo C; Cullen M; Taylor J; Short M; Glover P; Van Hoppe S; Smith A; Evans P; Crouch S
    Blood; 2019 Mar; 133(12):1325-1334. PubMed ID: 30606702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
    Patnaik MM; Tefferi A
    Mayo Clin Proc; 2016 Feb; 91(2):259-72. PubMed ID: 26848006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.